Company intelligence / Profile preview

MAGic Bioprocessing

Uppsala, Uppsala County, Swedenmagicbioprocessing.com ↗

Ownership: Private
Development stage: Commercial

Overview

MAGic Bioprocessing develops proprietary magnetic-based separation technologies that streamline the downstream processing of high-value biologics. Their patented systems enable scalable purification from lab to manufacturing scale, improving yield and reducing costs in biomanufacturing workflows. The company recently secured patents in the USA and China for its combinatory separation system used in the MAGic™ Accio platform. No clinical results as they do not develop therapeutics.

Modalities: Not directly therapeutic; provides enabling technologies for biologics including recombinant proteins, monoclonal antibodies, viral vectors, and cells
Industry: Non-Drug Biotech

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on MAGic Bioprocessing.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MAGic Bioprocessing.

Explore the full profile